SCIBASE AB Inactive Instrument
Scibase AB Stock Swiss Exchange
Equities
SE0007045414
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| Apr. 05 | SciBase Plans SEK48 Million Capital Raising for Commercialization, Growth in US | MT |
| Feb. 28 | SciBase to Offer Diagnostic Tool on Skinobs Cosmetic Testing Platform | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Pia Renaudin
CEO | Chief Executive Officer | 57 | 23-09-30 |
| Founder | 78 | 97-12-31 | |
Michael Colérus
DFI | Director of Finance/CFO | 62 | 13-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Matt L. Leavitt
BRD | Director/Board Member | - | 21-05-17 |
| Chairman | 67 | 13-12-31 | |
| Founder | 78 | 97-12-31 |
SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.
Calendar
2024-05-08
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -15.34% | 18.88B | |
| -41.10% | 2.84B | |
| +24.02% | 1.85B | |
| +8.62% | 1.66B | |
| +26.63% | 1.26B | |
| -7.74% | 989M | |
| -18.61% | 896M | |
| -1.03% | 757M | |
| -23.76% | 637M |
- Stock Market
- Equities
- Stock
- Stock